Table 3.

Post- operative weeks	Group	No. of animals examined	Incidence of
			Barrett’s esophagus	Carcinoma
10 W	Control	10	10%	0%
	Celecoxib	5	0%	0%
20 W	Control	10	40%	0%
	Celecoxib	5	20%	0%
30 W	Control	10	50%	10%
	Celecoxib	5	40%	0%
40 W	Control	19
	Celecoxib	8

^**p < 0.01

^*p < 0.05.